- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/12 - Antihypertensives
Patent holdings for IPC class A61P 9/12
Total number of patents in this class: 4051
10-year publication summary
|
107
|
170
|
239
|
215
|
222
|
244
|
257
|
235
|
229
|
35
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1875 |
67 |
| Novartis AG | 10463 |
66 |
| Takeda Pharmaceutical Company Limited | 2713 |
54 |
| Sunshine Lake Pharma Co., Ltd. | 613 |
39 |
| Actelion Pharmaceuticals Ltd | 519 |
38 |
| United Therapeutics Corporation | 317 |
35 |
| Mitsubishi Tanabe Pharma Corporation | 543 |
31 |
| Acceleron Pharma Inc. | 349 |
28 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
28 |
| Boehringer Ingelheim Vetmedica GmbH | 1280 |
25 |
| Shionogi & Co., Ltd. | 829 |
24 |
| F. Hoffmann-La Roche AG | 7875 |
23 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 184 |
21 |
| Bayer Pharma AG | 1036 |
20 |
| Mayo Foundation for Medical Education and Research | 3336 |
20 |
| Dainippon Sumitomo Pharma Co., Ltd. | 176 |
20 |
| Nippon Shinyaku Co., Ltd. | 327 |
20 |
| Regeneron Pharmaceuticals, Inc. | 4523 |
20 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3254 |
20 |
| Kowa Company, Ltd. | 1224 |
17 |
| Other owners | 3435 |